ARTICLE | Clinical News
GMDP glycopeptide data
June 3, 1996 7:00 AM UTC
Results of a physician-sponsored open-label study showed a reduction in Psoriasis Area and Severity Index, PTD said. Patients were given 20 mg/day of GMDP once a day for 14 days. The average decrease ...